1	3	_	_	CD	_	_	_	_	_
2	.	_	_	.	_	_	_	_	_


1	TRP	_	_	NN	_	_	_	_	_
2	Channels	_	_	NNS	_	_	_	_	_
3	in	_	_	IN	_	_	_	_	_
4	Colorectal	_	_	NNP	_	_	_	_	_
5	Cancers	_	_	NNPS	_	_	_	_	_


1	Colorectal	_	_	JJ	_	_	_	_	_
2	cancer	_	_	NN	_	_	_	_	_
3	(	_	_	-LRB-	_	_	_	_	_
4	CRC	_	_	NNP	_	_	_	_	_
5	)	_	_	-RRB-	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	the	_	_	DT	_	_	_	_	_
8	most	_	_	RBS	_	_	_	_	_
9	prevalent	_	_	JJ	_	_	_	_	_
10	cancer	_	_	NN	_	_	_	_	_
11	of	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	GI	_	_	NNP	_	_	_	_	_
14	tract	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	represents	_	_	VBZ	_	_	_	_	_
17	the	_	_	DT	_	_	_	_	_
18	third	_	_	JJ	_	_	_	_	_
19	most	_	_	RBS	_	_	_	_	_
20	commonly	_	_	RB	_	_	_	_	_
21	diagnosed	_	_	VBN	_	_	_	_	_
22	malignancy	_	_	NN	_	_	_	_	_
23	worldwide	_	_	RB	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	men	_	_	NNS	_	_	_	_	_
26	and	_	_	CC	_	_	_	_	_
27	women	_	_	NNS	_	_	_	_	_
28	and	_	_	CC	_	_	_	_	_
29	the	_	_	DT	_	_	_	_	_
30	second	_	_	JJ	_	_	_	_	_
31	largest	_	_	JJS	_	_	_	_	_
32	cause	_	_	NN	_	_	_	_	_
33	of	_	_	IN	_	_	_	_	_
34	death	_	_	NN	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	Europe	_	_	NNP	_	_	_	_	_
37	related	_	_	VBN	_	_	_	_	_
38	to	_	_	TO	_	_	_	_	_
39	cancer	_	_	NN	_	_	_	_	_
40	.	_	_	.	_	_	_	_	_


1	Growth	_	_	NN	_	_	_	_	_
2	factors	_	_	NNS	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	oncogenes	_	_	NNS	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	receptors	_	_	NNS	_	_	_	_	_
7	play	_	_	VBP	_	_	_	_	_
8	a	_	_	DT	_	_	_	_	_
9	critical	_	_	JJ	_	_	_	_	_
10	role	_	_	NN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	tumorigenesis	_	_	NN	_	_	_	_	_
14	,	_	_	,	_	_	_	_	_
15	and	_	_	CC	_	_	_	_	_
16	the	_	_	DT	_	_	_	_	_
17	propagation	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	CRC	_	_	NNP	_	_	_	_	_
20	.	_	_	.	_	_	_	_	_


1	However	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	environmental	_	_	JJ	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	genetic	_	_	JJ	_	_	_	_	_
7	factors	_	_	NNS	_	_	_	_	_
8	play	_	_	VBP	_	_	_	_	_
9	significant	_	_	JJ	_	_	_	_	_
10	roles	_	_	NNS	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	the	_	_	DT	_	_	_	_	_
13	development	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	CRC	_	_	NNP	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	Over	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	last	_	_	JJ	_	_	_	_	_
4	two	_	_	CD	_	_	_	_	_
5	decades	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	accumulating	_	_	VBG	_	_	_	_	_
8	evidence	_	_	NN	_	_	_	_	_
9	has	_	_	VBZ	_	_	_	_	_
10	demonstrated	_	_	VBN	_	_	_	_	_
11	that	_	_	IN	_	_	_	_	_
12	several	_	_	JJ	_	_	_	_	_
13	members	_	_	NNS	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	the	_	_	DT	_	_	_	_	_
16	TRP	_	_	NNP	_	_	_	_	_
17	family	_	_	NN	_	_	_	_	_
18	channels	_	_	NNS	_	_	_	_	_
19	show	_	_	VBP	_	_	_	_	_
20	altered	_	_	VBN	_	_	_	_	_
21	expression	_	_	NN	_	_	_	_	_
22	and	_	_	CC	_	_	_	_	_
23	activity	_	_	NN	_	_	_	_	_
24	in	_	_	IN	_	_	_	_	_
25	cancer	_	_	NN	_	_	_	_	_
26	cells	_	_	NNS	_	_	_	_	_
27	.	_	_	.	_	_	_	_	_


1	Levels	_	_	NNS	_	_	_	_	_
2	of	_	_	IN	_	_	_	_	_
3	expression	_	_	NN	_	_	_	_	_
4	of	_	_	IN	_	_	_	_	_
5	TRPC	_	_	NN	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	TRPM	_	_	NN	_	_	_	_	_
8	,	_	_	,	_	_	_	_	_
9	and	_	_	CC	_	_	_	_	_
10	TRPV	_	_	NN	_	_	_	_	_
11	proteins	_	_	NNS	_	_	_	_	_
12	depend	_	_	VBP	_	_	_	_	_
13	on	_	_	IN	_	_	_	_	_
14	the	_	_	DT	_	_	_	_	_
15	cancer	_	_	NN	_	_	_	_	_
16	stage	_	_	NN	_	_	_	_	_
17	.	_	_	.	_	_	_	_	_


1	Those	_	_	DT	_	_	_	_	_
2	differences	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	been	_	_	VBN	_	_	_	_	_
5	recognized	_	_	VBN	_	_	_	_	_
6	mainly	_	_	RB	_	_	_	_	_
7	in	_	_	IN	_	_	_	_	_
8	melanoma	_	_	NN	_	_	_	_	_
9	,	_	_	,	_	_	_	_	_
10	glioma	_	_	NN	_	_	_	_	_
11	and	_	_	CC	_	_	_	_	_
12	prostate	_	_	NN	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	breast	_	_	NN	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	kidney	_	_	NN	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	and	_	_	CC	_	_	_	_	_
19	bladder	_	_	NN	_	_	_	_	_
20	cancers	_	_	NNS	_	_	_	_	_
21	,	_	_	,	_	_	_	_	_
22	suggesting	_	_	VBG	_	_	_	_	_
23	an	_	_	DT	_	_	_	_	_
24	oncogenic	_	_	JJ	_	_	_	_	_
25	role	_	_	NN	_	_	_	_	_
26	for	_	_	IN	_	_	_	_	_
27	some	_	_	DT	_	_	_	_	_
28	TRPs	_	_	NNS	_	_	_	_	_
29	while	_	_	IN	_	_	_	_	_
30	others	_	_	NNS	_	_	_	_	_
31	may	_	_	MD	_	_	_	_	_
32	function	_	_	VB	_	_	_	_	_
33	as	_	_	IN	_	_	_	_	_
34	tumor	_	_	NN	_	_	_	_	_
35	suppressors	_	_	NNS	_	_	_	_	_
36	.	_	_	.	_	_	_	_	_


1	TRPs	_	_	NNS	_	_	_	_	_
2	activity	_	_	NN	_	_	_	_	_
3	implicates	_	_	VBZ	_	_	_	_	_
4	many	_	_	JJ	_	_	_	_	_
5	aspects	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	cancer	_	_	NN	_	_	_	_	_
8	development	_	_	NN	_	_	_	_	_
9	or	_	_	CC	_	_	_	_	_
10	“	_	_	``	_	_	_	_	_
11	hallmarks	_	_	NNS	_	_	_	_	_
12	of	_	_	IN	_	_	_	_	_
13	cancer	_	_	NN	_	_	_	_	_
14	”	_	_	''	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	such	_	_	JJ	_	_	_	_	_
17	as	_	_	IN	_	_	_	_	_
18	tumor	_	_	NN	_	_	_	_	_
19	migration	_	_	NN	_	_	_	_	_
20	and	_	_	CC	_	_	_	_	_
21	invasion	_	_	NN	_	_	_	_	_
22	,	_	_	,	_	_	_	_	_
23	exaggerated	_	_	VBN	_	_	_	_	_
24	cell	_	_	NN	_	_	_	_	_
25	proliferation	_	_	NN	_	_	_	_	_
26	,	_	_	,	_	_	_	_	_
27	cell	_	_	NN	_	_	_	_	_
28	survival	_	_	NN	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	angiogenesis	_	_	NN	_	_	_	_	_
31	,	_	_	,	_	_	_	_	_
32	and	_	_	CC	_	_	_	_	_
33	enhanced	_	_	VBN	_	_	_	_	_
34	resistance	_	_	NN	_	_	_	_	_
35	to	_	_	TO	_	_	_	_	_
36	cell	_	_	NN	_	_	_	_	_
37	death	_	_	NN	_	_	_	_	_
38	.	_	_	.	_	_	_	_	_


1	To	_	_	TO	_	_	_	_	_
2	date	_	_	VB	_	_	_	_	_
3	,	_	_	,	_	_	_	_	_
4	TRPV1	_	_	NNP	_	_	_	_	_
5	and	_	_	CC	_	_	_	_	_
6	TRPV6	_	_	NNP	_	_	_	_	_
7	have	_	_	VBP	_	_	_	_	_
8	been	_	_	VBN	_	_	_	_	_
9	exclusively	_	_	RB	_	_	_	_	_
10	recognized	_	_	VBN	_	_	_	_	_
11	as	_	_	IN	_	_	_	_	_
12	relevant	_	_	JJ	_	_	_	_	_
13	in	_	_	IN	_	_	_	_	_
14	CRC	_	_	NNP	_	_	_	_	_
15	carcinogenesis	_	_	NN	_	_	_	_	_
16	.	_	_	.	_	_	_	_	_


1	As	_	_	IN	_	_	_	_	_
2	mentioned	_	_	VBN	_	_	_	_	_
3	above	_	_	RB	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	the	_	_	DT	_	_	_	_	_
6	TRPV1	_	_	NNP	_	_	_	_	_
7	channel	_	_	NN	_	_	_	_	_
8	is	_	_	VBZ	_	_	_	_	_
9	also	_	_	RB	_	_	_	_	_
10	involved	_	_	VBN	_	_	_	_	_
11	in	_	_	IN	_	_	_	_	_
12	IBD	_	_	NNP	_	_	_	_	_
13	,	_	_	,	_	_	_	_	_
14	a	_	_	DT	_	_	_	_	_
15	chronic	_	_	JJ	_	_	_	_	_
16	disorder	_	_	NN	_	_	_	_	_
17	strongly	_	_	RB	_	_	_	_	_
18	correlated	_	_	VBN	_	_	_	_	_
19	with	_	_	IN	_	_	_	_	_
20	risk	_	_	NN	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	CRC	_	_	NNP	_	_	_	_	_
23	.	_	_	.	_	_	_	_	_


1	Animal	_	_	NN	_	_	_	_	_
2	models	_	_	NNS	_	_	_	_	_
3	have	_	_	VBP	_	_	_	_	_
4	demonstrated	_	_	VBN	_	_	_	_	_
5	a	_	_	DT	_	_	_	_	_
6	protective	_	_	JJ	_	_	_	_	_
7	role	_	_	NN	_	_	_	_	_
8	for	_	_	IN	_	_	_	_	_
9	TRPV1	_	_	NNP	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	the	_	_	DT	_	_	_	_	_
12	tumorigenesis	_	_	NN	_	_	_	_	_
13	of	_	_	IN	_	_	_	_	_
14	colon	_	_	NN	_	_	_	_	_
15	cancer	_	_	NN	_	_	_	_	_
16	,	_	_	,	_	_	_	_	_
17	indeed	_	_	RB	_	_	_	_	_
18	TRPV1-	_	_	NNP	_	_	_	_	_
19	Knockout	_	_	NNP	_	_	_	_	_
20	mice	_	_	NNS	_	_	_	_	_
21	exhibited	_	_	VBN	_	_	_	_	_
22	lower	_	_	JJR	_	_	_	_	_
23	expression	_	_	NN	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	anti-inflammatory	_	_	JJ	_	_	_	_	_
26	neuropeptides	_	_	NNS	_	_	_	_	_
27	and	_	_	CC	_	_	_	_	_
28	greater	_	_	JJR	_	_	_	_	_
29	occurrence	_	_	NN	_	_	_	_	_
30	and	_	_	CC	_	_	_	_	_
31	number	_	_	NN	_	_	_	_	_
32	of	_	_	IN	_	_	_	_	_
33	CRC	_	_	NNP	_	_	_	_	_
34	compared	_	_	VBN	_	_	_	_	_
35	with	_	_	IN	_	_	_	_	_
36	controls	_	_	NNS	_	_	_	_	_
37	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	accordance	_	_	NN	_	_	_	_	_
3	with	_	_	IN	_	_	_	_	_
4	these	_	_	DT	_	_	_	_	_
5	data	_	_	NNS	_	_	_	_	_
6	,	_	_	,	_	_	_	_	_
7	Sung	_	_	NNP	_	_	_	_	_
8	and	_	_	CC	_	_	_	_	_
9	colleagues	_	_	NNS	_	_	_	_	_
10	demonstrated	_	_	VBD	_	_	_	_	_
11	that	_	_	IN	_	_	_	_	_
12	agonist-mediated	_	_	JJ	_	_	_	_	_
13	activation	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	TRPV1	_	_	NNP	_	_	_	_	_
16	induced	_	_	VBD	_	_	_	_	_
17	apoptosis	_	_	NN	_	_	_	_	_
18	of	_	_	IN	_	_	_	_	_
19	CRC	_	_	NNP	_	_	_	_	_
20	cells	_	_	NNS	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_


1	On	_	_	IN	_	_	_	_	_
2	the	_	_	DT	_	_	_	_	_
3	other	_	_	JJ	_	_	_	_	_
4	hand	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	an	_	_	DT	_	_	_	_	_
7	overexpression	_	_	NN	_	_	_	_	_
8	of	_	_	IN	_	_	_	_	_
9	TRPV6	_	_	NN	_	_	_	_	_
10	in	_	_	IN	_	_	_	_	_
11	SW480	_	_	NN	_	_	_	_	_
12	colorectal	_	_	JJ	_	_	_	_	_
13	cancer	_	_	NN	_	_	_	_	_
14	cell	_	_	NN	_	_	_	_	_
15	lines	_	_	NNS	_	_	_	_	_
16	and	_	_	CC	_	_	_	_	_
17	colon	_	_	NN	_	_	_	_	_
18	carcinomas	_	_	NNS	_	_	_	_	_
19	have	_	_	VBP	_	_	_	_	_
20	been	_	_	VBN	_	_	_	_	_
21	associated	_	_	VBN	_	_	_	_	_
22	with	_	_	IN	_	_	_	_	_
23	an	_	_	DT	_	_	_	_	_
24	enhanced	_	_	VBN	_	_	_	_	_
25	proliferation	_	_	NN	_	_	_	_	_
26	of	_	_	IN	_	_	_	_	_
27	malignant	_	_	JJ	_	_	_	_	_
28	cells	_	_	NNS	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	In	_	_	IN	_	_	_	_	_
2	a	_	_	DT	_	_	_	_	_
3	recent	_	_	JJ	_	_	_	_	_
4	report	_	_	NN	_	_	_	_	_
5	,	_	_	,	_	_	_	_	_
6	Pérez-Riesgo	_	_	NNP	_	_	_	_	_
7	et	_	_	FW	_	_	_	_	_
8	al.	_	_	FW	_	_	_	_	_
9	have	_	_	VBP	_	_	_	_	_
10	assessed	_	_	VBN	_	_	_	_	_
11	differential	_	_	JJ	_	_	_	_	_
12	gene	_	_	NN	_	_	_	_	_
13	expression	_	_	NN	_	_	_	_	_
14	of	_	_	IN	_	_	_	_	_
15	all	_	_	DT	_	_	_	_	_
16	human	_	_	JJ	_	_	_	_	_
17	TRP	_	_	NN	_	_	_	_	_
18	channels	_	_	NNS	_	_	_	_	_
19	by	_	_	IN	_	_	_	_	_
20	Next	_	_	NNP	_	_	_	_	_
21	Generation	_	_	NNP	_	_	_	_	_
22	Sequencing	_	_	NN	_	_	_	_	_
23	(	_	_	-LRB-	_	_	_	_	_
24	NGS	_	_	NNP	_	_	_	_	_
25	)	_	_	-RRB-	_	_	_	_	_
26	to	_	_	TO	_	_	_	_	_
27	investigate	_	_	VB	_	_	_	_	_
28	differences	_	_	NNS	_	_	_	_	_
29	in	_	_	IN	_	_	_	_	_
30	expression	_	_	NN	_	_	_	_	_
31	of	_	_	IN	_	_	_	_	_
32	several	_	_	JJ	_	_	_	_	_
33	genes	_	_	NNS	_	_	_	_	_
34	involved	_	_	VBN	_	_	_	_	_
35	in	_	_	IN	_	_	_	_	_
36	intracellular	_	_	JJ	_	_	_	_	_
37	Ca2+	_	_	NN	_	_	_	_	_
38	transport	_	_	NN	_	_	_	_	_
39	in	_	_	IN	_	_	_	_	_
40	CRC	_	_	NNP	_	_	_	_	_
41	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	results	_	_	NNS	_	_	_	_	_
3	obtained	_	_	VBN	_	_	_	_	_
4	,	_	_	,	_	_	_	_	_
5	comparing	_	_	VBG	_	_	_	_	_
6	human	_	_	JJ	_	_	_	_	_
7	normal	_	_	JJ	_	_	_	_	_
8	colonic	_	_	JJ	_	_	_	_	_
9	cells	_	_	NNS	_	_	_	_	_
10	versus	_	_	IN	_	_	_	_	_
11	human	_	_	JJ	_	_	_	_	_
12	colon	_	_	NN	_	_	_	_	_
13	cancer	_	_	NN	_	_	_	_	_
14	lines	_	_	NNS	_	_	_	_	_
15	,	_	_	,	_	_	_	_	_
16	revealed	_	_	VBD	_	_	_	_	_
17	that	_	_	IN	_	_	_	_	_
18	only	_	_	RB	_	_	_	_	_
19	a	_	_	DT	_	_	_	_	_
20	dozen	_	_	CD	_	_	_	_	_
21	of	_	_	IN	_	_	_	_	_
22	the	_	_	DT	_	_	_	_	_
23	TRPs	_	_	NNS	_	_	_	_	_
24	are	_	_	VBP	_	_	_	_	_
25	expressed	_	_	VBN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	colonic	_	_	JJ	_	_	_	_	_
28	cells	_	_	NNS	_	_	_	_	_
29	,	_	_	,	_	_	_	_	_
30	either	_	_	CC	_	_	_	_	_
31	normal	_	_	JJ	_	_	_	_	_
32	or	_	_	CC	_	_	_	_	_
33	tumor	_	_	NN	_	_	_	_	_
34	.	_	_	.	_	_	_	_	_


1	The	_	_	DT	_	_	_	_	_
2	data	_	_	NNS	_	_	_	_	_
3	also	_	_	RB	_	_	_	_	_
4	indicated	_	_	VBD	_	_	_	_	_
5	that	_	_	IN	_	_	_	_	_
6	TRPV6	_	_	NNP	_	_	_	_	_
7	was	_	_	VBD	_	_	_	_	_
8	the	_	_	DT	_	_	_	_	_
9	unique	_	_	JJ	_	_	_	_	_
10	TRP	_	_	NN	_	_	_	_	_
11	gene	_	_	NN	_	_	_	_	_
12	significantly	_	_	RB	_	_	_	_	_
13	overexpressed	_	_	VBN	_	_	_	_	_
14	in	_	_	IN	_	_	_	_	_
15	CRC	_	_	NNP	_	_	_	_	_
16	cells	_	_	NNS	_	_	_	_	_
17	,	_	_	,	_	_	_	_	_
18	resembling	_	_	VBG	_	_	_	_	_
19	the	_	_	DT	_	_	_	_	_
20	previously	_	_	RB	_	_	_	_	_
21	reported	_	_	VBN	_	_	_	_	_
22	enhanced	_	_	VBN	_	_	_	_	_
23	levels	_	_	NNS	_	_	_	_	_
24	of	_	_	IN	_	_	_	_	_
25	TRPV6	_	_	NN	_	_	_	_	_
26	in	_	_	IN	_	_	_	_	_
27	prostate	_	_	NN	_	_	_	_	_
28	cancer	_	_	NN	_	_	_	_	_
29	.	_	_	.	_	_	_	_	_


1	Notwithstanding	_	_	RB	_	_	_	_	_
2	,	_	_	,	_	_	_	_	_
3	the	_	_	DT	_	_	_	_	_
4	functional	_	_	JJ	_	_	_	_	_
5	consequences	_	_	NNS	_	_	_	_	_
6	of	_	_	IN	_	_	_	_	_
7	changes	_	_	NNS	_	_	_	_	_
8	in	_	_	IN	_	_	_	_	_
9	expression	_	_	NN	_	_	_	_	_
10	of	_	_	IN	_	_	_	_	_
11	TRPV1	_	_	NNP	_	_	_	_	_
12	and	_	_	CC	_	_	_	_	_
13	TRPV6	_	_	NNP	_	_	_	_	_
14	channels	_	_	NNS	_	_	_	_	_
15	in	_	_	IN	_	_	_	_	_
16	CRC	_	_	NNP	_	_	_	_	_
17	remain	_	_	VBP	_	_	_	_	_
18	to	_	_	TO	_	_	_	_	_
19	be	_	_	VB	_	_	_	_	_
20	established	_	_	VBN	_	_	_	_	_
21	.	_	_	.	_	_	_	_	_

